CRISM National Injectable Opioid Agonist Treatment Guideline

CRISM developed the first national injectable opioid agonist treatment (iOAT) guideline in the world. This guideline includes two companion documents: a clinical guideline and an operational guidance document.

A synopsis of the Guideline was published in the Canadian Medical Association Journal.

Supplemental materials:

  • Supervised Consumption Sites vs iOAT | English | French
  • Sample Program Expectations | English | French
  • Sample Patient Bill of Rights | English | French
  • Sample Client Safety Care Plan | English | French
  • Sample Treatment Plan | English | French
  • Sample Floor Plan | English | French
  • Lessons Learned–Coming Soon
  • FAQ for Patients and Families–Coming soon
  • Case Studies–Coming soon
  • Sample Diacetylmorphine Titration Pre-Printed Order–Coming soon
  • Sample Hydromorphone Titration Pre-Printed Order–Coming soon
  • Sample Hydromorphone Titration Hospital Pre-Printed Order Package–Coming soon
  • Sample Hydromorphone Maintenance Pre-Printed Order–Coming soon